GlassScriptPhysician profile
Marla Turner Chapman
NPI 1114331832
$2,344.54
in general payments reported to CMS, 2019-2025
19 companies · $344 in 2025
The $344 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $102 · 2021: $387 · 2022: $432 · 2023: $462 · 2024: $300 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,072 · Debt Forgiveness: $34.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,071.90 |
| Debt Forgiveness | $34.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $296.02 | 2019-2025 | |
| Corium, LLC | $268.74 | 2022-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $224.14 | 2020-2022 | |
| Glaxosmithkline, LLC. | $203.30 | 2019-2025 | Pediarix, Bexsero |
| Tris Pharma INC | $200.25 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Merck Sharp & Dohme LLC | $164.61 | 2020-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Ironshore Pharmaceuticals INC. | $158.92 | 2019-2024 | Jornay Pm |
| Dexcom, INC. | $135.00 | 2025 | Dexcom G6 Transmitter |
| Sanofi Pasteur INC. | $116.34 | 2021-2025 | |
| Baxter Healthcare | $108.95 | 2022-2023 | |
| Sobi, INC | $108.52 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $87.04 | 2024-2025 | Dupixent |
| Welch Allyn | $57.62 | 2021 | |
| Shire North American Group INC | $50.14 | 2019 | |
| Supernus Pharmaceuticals, INC. | $47.98 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $46.25 | 2025 | Jornay Pm |
| Genzyme Corporation | $33.67 | 2019 | |
| Mission Pharmacal Company | $20.02 | 2019 | |
| Qol Medical, LLC | $17.03 | 2024 | Sucraid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.